vs
Burford Capital Ltd（BUR）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Burford Capital Ltd的1.1倍（$35.5M vs $33.4M），Burford Capital Ltd净利率更高（-112.2% vs -304.2%，领先192.0%），Burford Capital Ltd自由现金流更多（$-29.3M vs $-47.3M）
伯福德资本成立于2009年，是一家面向法律市场的专业金融服务提供商，总部位于根西岛，业务覆盖全球。该公司为企业法务部门、律师事务所的诉讼、仲裁、资产追回等相关法律活动提供资金支持，同时也提供配套的法律金融咨询服务。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
BUR vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.1倍
$33.4M
净利率更高
BUR
高出192.0%
-304.2%
自由现金流更多
BUR
多$18.0M
$-47.3M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $33.4M | $35.5M |
| 净利润 | $-37.5M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | -37.9% | -304.8% |
| 净利率 | -112.2% | -304.2% |
| 营收同比 | — | 681.7% |
| 净利润同比 | — | 39.6% |
| 每股收益（稀释后） | $-0.16 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BURRXRX
| Q4 25 | $33.4M | $35.5M | ||
| Q3 25 | $69.8M | $5.2M | ||
| Q2 25 | $191.3M | $19.2M | ||
| Q1 25 | $118.9M | $14.7M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | $159.7M | $26.1M | ||
| Q2 24 | $44.3M | $14.4M | ||
| Q1 24 | — | $13.8M |
净利润BURRXRX
| Q4 25 | $-37.5M | $-108.1M | ||
| Q3 25 | $-19.2M | $-162.3M | ||
| Q2 25 | $88.3M | $-171.9M | ||
| Q1 25 | $30.9M | $-202.5M | ||
| Q4 24 | — | $-178.9M | ||
| Q3 24 | $53.7M | $-95.8M | ||
| Q2 24 | $-29.9M | $-97.5M | ||
| Q1 24 | — | $-91.4M |
毛利率BURRXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率BURRXRX
| Q4 25 | -37.9% | -304.8% | ||
| Q3 25 | 35.5% | -3327.6% | ||
| Q2 25 | 74.3% | -916.8% | ||
| Q1 25 | 65.4% | -1297.9% | ||
| Q4 24 | — | -4042.4% | ||
| Q3 24 | 76.1% | -377.1% | ||
| Q2 24 | 32.0% | -697.4% | ||
| Q1 24 | — | -698.4% |
净利率BURRXRX
| Q4 25 | -112.2% | -304.2% | ||
| Q3 25 | -27.4% | -3135.3% | ||
| Q2 25 | 46.2% | -894.2% | ||
| Q1 25 | 26.0% | -1373.3% | ||
| Q4 24 | — | -3935.5% | ||
| Q3 24 | 33.7% | -367.5% | ||
| Q2 24 | -67.6% | -676.6% | ||
| Q1 24 | — | -662.4% |
每股收益（稀释后）BURRXRX
| Q4 25 | $-0.16 | $-0.17 | ||
| Q3 25 | $-0.09 | $-0.36 | ||
| Q2 25 | $0.39 | $-0.41 | ||
| Q1 25 | $0.14 | $-0.50 | ||
| Q4 24 | — | $-0.56 | ||
| Q3 24 | $0.24 | $-0.34 | ||
| Q2 24 | $-0.14 | $-0.40 | ||
| Q1 24 | — | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $943.5M | $743.3M |
| 总债务越低越好 | $2.1B | $9.6M |
| 股东权益账面价值 | $2.4B | $1.1B |
| 总资产 | $6.6B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.87× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资BURRXRX
| Q4 25 | $943.5M | $743.3M | ||
| Q3 25 | $677.7M | $659.8M | ||
| Q2 25 | $372.2M | $525.1M | ||
| Q1 25 | $486.6M | $500.5M | ||
| Q4 24 | — | $594.4M | ||
| Q3 24 | — | $427.6M | ||
| Q2 24 | — | $474.3M | ||
| Q1 24 | — | $296.3M |
总债务BURRXRX
| Q4 25 | $2.1B | $9.6M | ||
| Q3 25 | $2.1B | $11.9M | ||
| Q2 25 | $1.8B | $14.2M | ||
| Q1 25 | $1.8B | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益BURRXRX
| Q4 25 | $2.4B | $1.1B | ||
| Q3 25 | $2.5B | $1.0B | ||
| Q2 25 | $2.5B | $919.1M | ||
| Q1 25 | $2.4B | $933.9M | ||
| Q4 24 | — | $1.0B | ||
| Q3 24 | $3.2B | $524.6M | ||
| Q2 24 | $3.1B | $584.4M | ||
| Q1 24 | — | $401.2M |
总资产BURRXRX
| Q4 25 | $6.6B | $1.5B | ||
| Q3 25 | $6.7B | $1.4B | ||
| Q2 25 | $6.3B | $1.3B | ||
| Q1 25 | $6.2B | $1.3B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $726.5M | ||
| Q2 24 | — | $775.9M | ||
| Q1 24 | — | $557.8M |
负债/权益比BURRXRX
| Q4 25 | 0.87× | 0.01× | ||
| Q3 25 | 0.86× | 0.01× | ||
| Q2 25 | 0.71× | 0.02× | ||
| Q1 25 | 0.72× | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-29.0M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-29.3M | $-47.3M |
| 自由现金流率自由现金流/营收 | -87.7% | -133.1% |
| 资本支出强度资本支出/营收 | 0.8% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $21.4M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流BURRXRX
| Q4 25 | $-29.0M | $-46.1M | ||
| Q3 25 | $-20.1M | $-117.4M | ||
| Q2 25 | $-84.2M | $-76.4M | ||
| Q1 25 | $155.2M | $-132.0M | ||
| Q4 24 | — | $-115.4M | ||
| Q3 24 | $-97.4M | $-59.2M | ||
| Q2 24 | $53.0M | $-82.2M | ||
| Q1 24 | — | $-102.3M |
自由现金流BURRXRX
| Q4 25 | $-29.3M | $-47.3M | ||
| Q3 25 | $-20.1M | $-117.6M | ||
| Q2 25 | $-84.3M | $-79.6M | ||
| Q1 25 | $155.1M | $-133.8M | ||
| Q4 24 | — | $-116.7M | ||
| Q3 24 | $-97.4M | $-63.8M | ||
| Q2 24 | $52.9M | $-83.4M | ||
| Q1 24 | — | $-109.0M |
自由现金流率BURRXRX
| Q4 25 | -87.7% | -133.1% | ||
| Q3 25 | -28.8% | -2272.5% | ||
| Q2 25 | -44.1% | -413.9% | ||
| Q1 25 | 130.5% | -907.4% | ||
| Q4 24 | — | -2567.7% | ||
| Q3 24 | -61.0% | -244.6% | ||
| Q2 24 | 119.5% | -578.5% | ||
| Q1 24 | — | -789.9% |
资本支出强度BURRXRX
| Q4 25 | 0.8% | 3.5% | ||
| Q3 25 | 0.1% | 4.7% | ||
| Q2 25 | 0.1% | 16.4% | ||
| Q1 25 | 0.0% | 12.4% | ||
| Q4 24 | — | 28.6% | ||
| Q3 24 | 0.0% | 17.5% | ||
| Q2 24 | 0.1% | 8.2% | ||
| Q1 24 | — | 48.2% |
现金转化率BURRXRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.95× | — | ||
| Q1 25 | 5.02× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -1.81× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BUR
| Principal Finance Segment | $29.1M | 87% |
| Other | $3.5M | 10% |
| Management Fee Income | $878.0K | 3% |
RXRX
暂无分部数据
